Curtis Pickert - 13 Feb 2023 Form 3 Insider Report for Pediatrix Medical Group, Inc. (MD)

Role
EVP, Chief Operating Officer
Signature
/s/ Mary Ann E. Moore, Attorney-in-Fact
Issuer symbol
MD
Transactions as of
13 Feb 2023
Net transactions value
$0
Form type
3
Filing time
22 Feb 2023, 16:00:52 UTC
Next filing
03 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MD Common Stock 29,246 13 Feb 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan. 8,284 shares vest on March 1, 2023, 1,542 shares vest on June 1, 2023, 8,167 shares vest on March 1, 2024, 3,083 shares vest on June 1, 2024 and 8,170 shares vest on March 1, 2025.

Remarks:

See Exhibit 24.1 - Power of Attorney